Articles On Telix Pharmaceuticals (ASX:TLX)
Title | Source | Codes | Date |
---|---|---|---|
Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update
MELBOURNE, Australia, Jan. 9, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at the 41st Annual J.P. Morgan Healthcare Conference (9 – 12 January) in San Francisco. As pa... |
FNArena | TLX | 1 year ago |
ASX Close: Miners rally on China property stimulus
The share market snapped a run of four straight weekly declines following reports China may relax restrictions on property developers. The S&P/ASX 200 rallied 46 points or 0.65 per cent this afternoon to its third straight gain of th... |
themarketherald.com.au | TLX | 1 year ago |
ASX Update: Miners lead as China hopes lift market
Resource stocks steered the ASX towards a third day of gains and a winning week to start 2023 despite pressure on Wall Street. The S&P/ASX 200 climbed 35 points or 0.5 per cent by mid-session. The heavily-weighted materials sector... |
themarketherald.com.au | TLX | 1 year ago |
CLOSING BELL: ‘Burning cash, with a hint of Musk’ revealed as Tesla’s latest new car smell
ASX 200 benchmark climbs 1.5% during an otherwise super-quiet day Tesla dives 12.2% and Apple slips back under US$2T market cap Extra-special bonus: The greatest sporting achievement we’re gonna see all year Welcome to the end of the fi... |
Stockhead | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) recovered from Tuesdayâs fall today, lifting 1.63% to close at 7,059.2 points. Its gains came despite a rough nightâs trade on Wall Street. The Dow Jones Industrial Average Index (DJX: .DJI) traded... |
Motley Fool | TLX | 1 year ago |
ASX Large Caps: Local shares buck Wall Street as buyers come back to the market
The ASX had its first positive day of gains in 2023 Tesla could still be overpriced despite a 70% fall – expert US Fed meeting minutes due out tonight The ASX recorded its first day of gains for the year as financial and tech stocks led... |
Stockhead | TLX | 1 year ago |
ASX Close: Eight-week low as China worries mount
A new year got off to a challenging start with Australian stocks at eight-week lows as a month-long retreat continued in the wake of soft economic signals from major trading partner China. The S&P/ASX 200 slumped 92.5 points or 1.3... |
themarketherald.com.au | TLX | 1 year ago |
Bell Potter names the ASX healthcare shares to buy in 2023
If youâre interested in adding some healthcare sector exposure to your portfolio, then it could be worth taking a look at what Bell Potter is recommending. It has named its top picks in the healthcare sector for 2023 and the two ASX heal... |
Motley Fool | TLX | 1 year ago |
ASX Update: Heavy selling resumes as 2023 brings no relief
The share market slumped to an eight-week low as signs of a sharp slowdown in major trading partner China offset positive leads from European stocks. At the halfway mark, the S&P/ASX 200 was down 127 points or 1.81 per cent after a b... |
themarketherald.com.au | TLX | 1 year ago |
The 3 best-performing ASX 200 healthcare shares of 2022 revealed
Soaring inflation and rising interest rates plagued share markets in 2022, ultimately sending the S&P/ASX 200 Index (ASX: XJO) down 5.5%. Despite being known for their defensive qualities, ASX 200 healthcare shares werenât spared fro... |
Motley Fool | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
Ending the year on a high note, the S&P/ASX 200 Index (ASX: XJO) rallied on the last trading day of 2022. The benchmark index climbed 0.26% to 7,038.7 points, following in the footsteps of the US stock market last night. Nearly all se... |
Motley Fool | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
If investors weren’t already sick of 2022, today’s performance of the S&P/ASX 200 Index (ASX: XJO) was yet another nudge to the downside. By the end of the day, the benchmark index was 0.94% lower at 7,020.1 points. While the rest of... |
Motley Fool | TLX | 1 year ago |
Australian market closes in red, energy and utilities fall
Highights The ASX 200 benchmark index closed in the red today (December 29), losing 69.00 points or 0.97% to end at 7,017.40 points. The index has lost 1.89% over the last five days, and 6.56% over the last 52 weeks. Energy was the wo... |
Kalkine Media | TLX | 1 year ago |
ASX Close: Seven-week low as market faces 2023 challenges
The share market closed at a seven-week low following solid falls on Wall Street amid fears of another challenging year ahead as rising interest rates crimp corporate profits. The S&P/ASX 200 dropped 66 points or 0.94 per cent to its... |
themarketherald.com.au | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
Thursday was another good day on the S&P/ASX 200 Index (ASX: XJO). It closed 0.53% higher at 7,152.5 points. In the lead today was the S&P/ASX 200 Utilities Index (ASX: XUJ). The sector soared 1.6% as all three of its constituents... |
Motley Fool | TLX | 1 year ago |
ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances
Complete data from global Phase III ZIRCON study of Telix’s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) will be presented at American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancer... |
FNArena | TLX | 1 year ago |
The A to Z of Dr Boreham’s Crucible in 2022
The long and short of 2022 is that it was a frustrating period for the Australian biotech sector but one with its fair share of rewards as the sector’s exponents furthered worthy drugs, diagnostics, devices and doodahs. For the sixth year,... |
Stockhead | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) traded in the green on Tuesday, recovering some of yesterdayâs slump. At the end of todayâs session, the index was 0.31% higher at 7,203.3 points Tech shares were among the marketâs best performe... |
Motley Fool | TLX | 1 year ago |
Telix Announces Executive Leadership Appointments
MELBOURNE, Australia, Dec. 5, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces several key executive leadership appointments and promotions, reflecting the increased commercial focus of the... |
FNArena | TLX | 1 year ago |
A 10-year outlook, crypto inside Super, Telix Pharma, changes to advice, IVV stock split and more
Owen Rask and Drew Meredith are back on The Australian Investors Podcast for 2 Sense. This week, Drew and Owen talk crypto, getting financial advice, SMSFs, IVV’s stock split and JP Morgan Asset Management’s 10 year macro outlook. And of co... |
Rask Media | TLX | 1 year ago |
Skin in the game: The ASX share in my portfolio I’m most excited about
According to Oxford Languages, âmotleyâ means âincongruously varied in appearance or characterâ. But in relation to our Foolish writers, it means they vary greatly with regard to age, risk tolerance, and stage of life as well as in... |
Motley Fool | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) recovered yesterdayâs slump and then some today. It closed Tuesdayâs session 0.59% higher at 7,181.3 points. Thatâs despite major commodities, including oil, iron ore, and gold all having fallen o... |
Motley Fool | TLX | 1 year ago |
First Patient Dosed in Phase II ‘IPAX-Linz’ Study of TLX101 for Glioblastoma Therapy
MELBOURNE, Australia, Nov. 22, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in a Phase II investigator-initiated study of TLX101 in combination with... |
FNArena | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) slipped on Tuesday as lithium stocks weighed on the market. The index closed 0.07% lower at 7,141.6 points. It followed a weak session on Wall Street overnight in which the Dow Jones Industrial Average... |
Motley Fool | TLX | 1 year ago |
BRIEF-Telix Pharmaceuticals Acquires Optimal Tracers
Nov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH CALIFORNIA BASED PET IMAGING CENTER TO ACQUIRE OPTIMAL TRACERS Source text for Eikon: Further company coverage: |
Kalkine Media | TLX | 1 year ago |
Telix Pharmaceuticals (ASX:TLX) acquires Optimal Tracers
Telix Pharmaceuticals (TLX) enters an agreement with Northern California PET Imaging Center to acquire radiochemistry specialist Optimal TracersThe company believes the acquisition will “bolster” its in-house radiochemistry development capa... |
themarketherald.com.au | TLX | 1 year ago |
BRIEF-Telix Pharmaceuticals Acquires Optimal Tracers
Nov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH CALIFORNIA BASED PET IMAGING CENTER TO ACQUIRE OPTIMAL TRACERS Source text for Eikon: Further company coverage: |
Kalkine Media | TLX | 1 year ago |
BRIEF-Telix Pharmaceuticals Acquires Optimal Tracers
Nov 14 (Reuters) - Telix Pharmaceuticals: * TELIX ACQUIRES OPTIMAL TRACERS * ENTERED AGREEMENT WITH CALIFORNIA BASED PET IMAGING CENTER TO ACQUIRE OPTIMAL TRACERS Source text for Eikon: Further company coverage: |
Kalkine Media | TLX | 1 year ago |
Why Wilsons is tipping 24% upside for the Telix Pharmaceuticals share price
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is having a volatile day. The biopharmaceutical companyâs shares were pushing higher in early trade but have now dropped into the red. At the time of writing, the Telix share price is... |
Motley Fool | TLX | 1 year ago |
Telix Acquires Optimal Tracers
MELBOURNE, Australia and INDIANAPOLIS, Ind., Nov. 14, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Sacramento-based Northern California PET Im... |
FNArena | TLX | 1 year ago |
3 ASX shares to buy in a sector ready to explode: expert
It might be hard to believe after a crazy volatile 2022, but the S&P/ASX 200 Index (ASX: XJO) is still well up since the start of the COVID-19 pandemic. However, according to Wilsons equity strategist Rob Crookston, there is one usual... |
Motley Fool | TLX | 1 year ago |
Telix to Present at Jefferies London Healthcare Conference 2022
MELBOURNE, Australia, Nov. 11, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a commercial-stage biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic... |
FNArena | TLX | 1 year ago |
Materials leads market higher: ASX up 0.6% at close
ShareCafeMaterials leads market higher: ASX up 0.6% at close by Peter Milios Materials is the strongest sector by far in today’s trading. This was due to the initial possibility that China would begin to ease COVID restrictions. As such,... |
ShareCafe | TLX | 1 year ago |
How are these three ASX-listed healthcare shares faring today?
Highlights: Australia’s highly comprehensive healthcare system consists of two broad categories, the public and the private healthcare system. The public healthcare system is called Medicare, and it offers free healthcare services to... |
Kalkine Media | TLX | 1 year ago |
Strict Chinese measures dampen market sentiment: ASX up 0.29% at lunch
ShareCafeStrict Chinese measures dampen market sentiment: ASX up 0.29% at lunch by Lauren Hayes US markets finished higher on Friday after a volatile session following the release of the October jobs report, which showed better-than-expec... |
ShareCafe | TLX | 1 year ago |
Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study
Summary of Study Outcomes ZIRCON Phase III study of Telix’s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met all of its primary and secondary endpoints The study delivered co-primary endpoints... |
FNArena | TLX | 1 year ago |
Life sciences industry’s highest achievers celebrated at prestigious Awards ceremony
AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards Industry Leadership Award: Professors Steve Wilton AO and Sue Fletcher AO Company of the Year: Telix Pharmaceuticals Emerging Company of the Year: Fusetec AusBi... |
FNArena | TLX | 1 year ago |
Telix Recognised as Company of the Year at AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2022
MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is today pleased to announce that it has been awarded Australian Company of the Year in the 2022 AusBiotech and Johnson &... |
FNArena | TLX | 1 year ago |
Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide
MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a collaboration with UniQuest Pty Ltd (UniQuest), the commercialisation company of The University of Queensla... |
FNArena | TLX | 1 year ago |
ASX Today: Stocks to roar as rates expectations ease
Australian shares were set to surge after hints of a slowdown in US interest rate rises fuelled a strong end to Wall Street’s best week since June. Wall Street’s main indices jumped more than 2.3 per cent on Friday, priming the S&P/A... |
themarketherald.com.au | TLX | 1 year ago |
ASX Large Caps: Coal stocks gain; Novonix in hot water over disclosure
The ASX closed lower on Friday, extending its loss to over 1% for the week Coal and energy stocks gained, while insurance stocks fell Novonix in hot water with the ASX Local shares fell close to 1% on Friday, ending what has been a vola... |
Stockhead | TLX | 1 year ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) ended the week in the red once more. The index fell 0.8% to 6,676.8 points on Friday. That leaves it 1.21% lower than it finished last weekâs trade. It followed a rough Thursday for New York-listed st... |
Motley Fool | TLX | 1 year ago |
ASX 200 closes in red; energy gains, utilities leads losses
Highlights The ASX 200 benchmark index closed down today (21 October), losing 53.90 points or 0.80% to end at 6,676.80 points. Over the last five days, the index has lost 1.21% and 9.96% over the last 52 weeks. Utilities and materials... |
Kalkine Media | TLX | 1 year ago |
ASX Close: Banks steer market lower as yields rise
The share market wrapped up a losing week with a second-straight decline as borrowing costs on both sides of the Pacific tested multi-year highs. The S&P/ASX 200 dropped 54 points or 0.8 per cent this afternoon to 6677. For the we... |
themarketherald.com.au | TLX | 1 year ago |
Grim start to last trading day for the week: ASX down 0.8%
ShareCafeGrim start to last trading day for the week: ASX down 0.8% by Peter Milios Energy and Information Technology are the only sectors up at noon, as the ASX looks to close out a pretty moderate week. The energy sector got a boost fro... |
ShareCafe | TLX | 1 year ago |
ASX Update: Banks weigh as recession worries continue
A losing week on the ASX headed towards a downbeat conclusion as declines in banks and industrial companies outweighed slender gains in resource stocks. The S&P/ASX 200 fell 39 points or 0.6 per cent towards a second straight loss af... |
themarketherald.com.au | TLX | 1 year ago |
Vida Ventures MD says it’s a rosy outlook for biotech investment in Australia in the long run
27 new biotech companies listed on the ASX the last two years Australian companies need access to US capital to grow The AusBiotech investment conference kicks off next week in WA The Covid-19 pandemic put Australia’s biotechnology sect... |
Stockhead | TLX | 1 year ago |
ASX Close: Shares slide as labour market slows
Australian shares tracked Wall Street lower after the cost of borrowing rose and the jobs market showed early signs of slowing. The S&P/ASX 200 declined 69 points or 1.02 per cent to 6731. The retreat continued a burst of moves of... |
themarketherald.com.au | TLX | 1 year ago |
ASX Update: Jobs miss, rates woes pressure stocks
Australian shares fell for the first time in three sessions as record results from energy giants Woodside and Santos were overshadowed by weak jobs data and renewed worries about rising rates. The S&P/ASX 200 dropped 78 points or 1.1... |
themarketherald.com.au | TLX | 1 year ago |
ASX Quarterlies: The BNPL turnaround we’ve been waiting for? Zip delivers, share price up 5pc
It’s quarterlies season again as the ASX market announcements page becomes increasingly flooded with earnings lodgements. The highlight today came from BNPL stock Zip, which reported strong growth. Is this the start of the BNPL turnaround... |
Stockhead | TLX | 1 year ago |